GlassScriptPhysician profile
Dennis R Good
NPI 1538414909
$15,304.09
in general payments reported to CMS, 2019-2025
10 companies · $9,651 in 2025
The $9,651 reported for 2025 was more than what 99% of Medical providers received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $119 · 2022: $845 · 2023: $894 · 2024: $3,795 · 2025: $9,651.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Long Term Medical Supply Or Device Loan: $13K · Food and Beverage: $1,674.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Long Term Medical Supply Or Device Loan | $12,666.67 |
| Food and Beverage | $1,673.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Angiodynamics, INC. | $12,666.67 | 2024-2025 | Auryon Laser System 100-120 Vac |
| Bard Peripheral Vascular, INC. | $1,279.84 | 2022-2025 | Venclose Maven Catheter |
| Boston Scientific Corporation | $509.35 | 2022-2025 | Eluvia, Avvigo Guidance System, Varithena Administration Pack |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $244.02 | 2022-2024 | Lifevest |
| Medtronic, INC. | $213.68 | 2021-2025 | Closurefast, Venaseal |
| Pfizer INC. | $146.23 | 2021-2024 | |
| Amgen INC. | $131.84 | 2023 | Repatha |
| Novartis Pharmaceuticals Corporation | $50.76 | 2023-2024 | |
| Merck Sharp & Dohme LLC | $40.84 | 2023 | Verquvo |
| Tactile Systems Technology INC | $20.86 | 2024 | Flexitouch Plus, Entre Plus |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dennis Good listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.